Allergic rhinitis
Conditions
Interventions
Sponsors
Assoc. Prof. Dr. Supanimit Teekachunhatean
Eligibility
Sex/Gender
Male
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: Out-patients of either sex, 18-60 years of age, suffering from persistent allergic rhinitis (PER) according to the Allergic Rhinitis and its Impact on Asthma (ARIA) World Health Organization (WHO) guideline as: duration of symptoms > 4 days/week and > 4 weeks, positive skin prick test response to 1 or more allergen. Total nasal symptom scores must be > or = 6 in the 2 previous weeks. All patients have to sign the written consent form to participate in the study.
Exclusion criteria
Exclusion criteria: Patients must not have the following diseases or conditions: structural abnormalities of the nose such as deviated nasal septum and nasal polyps, acute or chronic upper respiratory tract infection within the last 2 weeks, use of oral or topical nasal steroid within the last 4 weeks, immunotherapy within the last 1 year, nasal surgery within the last 4 weeks, history of asthma, cardiovascular diseases, uncontrolled hypertension, cancer, diabetes mellitus, benign prostatic hyperplasia, liver or kidney diseases, clinically significant abnormalities in blood chemistry and hematology, pregnancy and lactation.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Total nasal symptom score; | — |
Countries
Thailand
Contacts
Public ContactAssoc. Prof. Dr. Supanimit Teekachunhatean
Outcome results
None listed